EAU 2021: State-of-the-Art Lecture Immunotherapy-Based Management of Metastatic Clear-Cell and Variant RCC: What Can We Achieve?

(UroToday.com) Dr. Ignacio Durán, a medical oncologist from Spain, provides an excellent state-of-the-art lecture on the current immunotherapy-based management of metastatic clear cell RCC and variant RCC. He provides a historical perspective, the current status of therapy, and what we can potentially achieve.